The prevalence of type 2 diabetes in children and adolescents is rapidly increasing along with the epidemic of childhood obesity worldwide. Since the international society for pediatric and adolescent diabetes (ISPAD) published guideline on the topic of type 2 diabetes in children and adolescents in 2018, evidence of evidence-based medical research for this population has been reported in large cohort studies. Therefore, in November 2022, ISPAD issued a new edition of guideline for the management of type 2 diabetes in children and adolescents. The guideline focuses on risk factors, screening and diagnosis, pharmacotherapy, and management of comorbidities and complications of type 2 diabetes in children and adolescents. The new edition of the guideline provides important guidance for the standardized management of type 2 diabetes in children and adolescents.

Type 2 diabetes; Children and adolescents; International society for pediatric and adolescent diabetes; Interpretation of guidelines